KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Liabilities: 2009-2024

Historic Total Liabilities for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $1.7 billion.

  • Idexx Laboratories' Total Liabilities rose 5.36% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 5.36%. This contributed to the annual value of $1.7 billion for FY2024, which is 4.35% down from last year.
  • Per Idexx Laboratories' latest filing, its Total Liabilities stood at $1.7 billion for FY2024, which was down 4.35% from $1.8 billion recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Total Liabilities registered a high of $2.1 billion during FY2022, and its lowest value of $1.7 billion during FY2020.
  • Moreover, its 3-year median value for Total Liabilities was $1.8 billion (2023), whereas its average is $1.9 billion.
  • In the last 5 years, Idexx Laboratories' Total Liabilities increased by 22.37% in 2022 and then declined by 16.96% in 2023.
  • Idexx Laboratories' Total Liabilities (Yearly) stood at $1.7 billion in 2020, then grew by 5.14% to $1.7 billion in 2021, then rose by 22.37% to $2.1 billion in 2022, then fell by 16.96% to $1.8 billion in 2023, then declined by 4.35% to $1.7 billion in 2024.